Related Experiment Video
Updated: Jun 3, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries
1Department of Respiratory Medicine, 3rd Floor, Woolworths Building, Royal Children's Hospital, Herston, QLD 4029, Australia. dr.nitinkapur@gmail.com
Non-CF bronchiectasis causes significant illness globally, with higher prevalence in indigenous populations. More research is needed to understand its incidence and prevalence in developing nations.
Area of Science:
- Pulmonology
- Epidemiology
Background:
- Non-CF bronchiectasis is a significant cause of illness worldwide, particularly in developing countries and among indigenous populations.
- While prevalence declines in developed nations, it remains high in certain indigenous groups, highlighting a need for focused research.
Purpose of the Study:
- To emphasize the need for epidemiological studies to determine the incidence and prevalence of non-CF bronchiectasis in developing countries.
- To highlight the differences in etiology, nutritional status, exacerbation frequency, and disease severity between developing and affluent countries.
Main Methods:
- This study is a review and synthesis of existing data and literature on non-CF bronchiectasis.
- It identifies gaps in epidemiological data, particularly for developing nations.
Main Results:
- Prevalence is increasing in indigenous populations, even in affluent countries.
- Despite similarities in core characteristics, etiological factors and disease severity vary significantly between developing and developed regions.
- Diagnostic delays are common in both settings, albeit for different reasons.
Conclusions:
- Epidemiological data on non-CF bronchiectasis in developing countries are lacking and urgently required.
- Evidence-based management necessitates long-term studies.
- Multidisciplinary approaches are crucial for effective management and prevention, though resource limitations in developing countries pose a major challenge.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

